MX2015011540A - Solucion de electrolitos orales que contiene lactoferrina y usos de la misma. - Google Patents
Solucion de electrolitos orales que contiene lactoferrina y usos de la misma.Info
- Publication number
- MX2015011540A MX2015011540A MX2015011540A MX2015011540A MX2015011540A MX 2015011540 A MX2015011540 A MX 2015011540A MX 2015011540 A MX2015011540 A MX 2015011540A MX 2015011540 A MX2015011540 A MX 2015011540A MX 2015011540 A MX2015011540 A MX 2015011540A
- Authority
- MX
- Mexico
- Prior art keywords
- electrolyte solution
- lactoferrin
- oral electrolyte
- reducing
- solution containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C17/00—Buttermilk; Buttermilk preparations
- A23C17/02—Buttermilk; Buttermilk preparations containing, or treated with, microorganisms or enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente invención se refiere a una solución de electrolitos orales que comprende lactoferrina. La lactoferrina puede promover el sanado intestinal durante un ataque de diarrea en un sujeto pediátrico, reduciendo por esto la duración de los síntomas de la diarrea. Adicionalmente, las soluciones de electrolitos orales descritas aquí pueden comprender el Lactobacillus rhamnosus GG, la vitamina B3 y/o una fuente de zinc. La descripción se refiere además a métodos de reducción de la duración de los síntomas de la diarrea y de reducción de la irritación gastrointestinal en un sujeto pediátrico por la provisión de una solución de electrolitos orales que comprende lactoferrina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/794,014 US20140255365A1 (en) | 2013-03-11 | 2013-03-11 | Oral Electrolyte Solution Containing Lactoferrin and Uses Thereof |
PCT/US2014/015811 WO2014143471A1 (en) | 2013-03-11 | 2014-02-11 | Oral electrolyte solution containing lactoferrin and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2015011540A true MX2015011540A (es) | 2016-02-05 |
Family
ID=50239940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015011540A MX2015011540A (es) | 2013-03-11 | 2014-02-11 | Solucion de electrolitos orales que contiene lactoferrina y usos de la misma. |
Country Status (14)
Country | Link |
---|---|
US (1) | US20140255365A1 (es) |
EP (1) | EP2968305A1 (es) |
CN (1) | CN105120888A (es) |
AR (1) | AR095082A1 (es) |
AU (1) | AU2014228654B2 (es) |
BR (1) | BR112015020864A2 (es) |
CA (1) | CA2904221A1 (es) |
HK (1) | HK1218070A1 (es) |
MX (1) | MX2015011540A (es) |
PE (1) | PE20151883A1 (es) |
PH (1) | PH12015501803A1 (es) |
RU (1) | RU2015132613A (es) |
SG (1) | SG11201505529SA (es) |
WO (1) | WO2014143471A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11197917B2 (en) | 2017-12-01 | 2021-12-14 | ByHeart, Inc. | Formulations for nutritional support in subjects in need thereof |
GR1009632B (el) | 2018-07-09 | 2019-10-25 | Ιουλια Κλεωνος Τσετη | Διατροφικο συμπληρωμα για την απο του στοματος χορηγηση συνδυασμου λακτοφερινης, ξυλογλυκανης, προανθοκυανιδινων και σιμεθικονης, χρησιμων για την προληψη λοιμωξεων του γαστρεντερικου και ουροποιητικου συστηματος |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE61701B1 (en) | 1986-07-17 | 1994-11-30 | Morinaga Milk Industry Co Ltd | Process for producing bovine lactoferrin in high purity |
NZ330484A (en) | 1994-02-16 | 1999-11-29 | Pharming Bv | Isolation of lactoferrin especially recombinant lactoferrin from milk |
SE523771C2 (sv) * | 1999-05-21 | 2004-05-18 | Probi Ab | Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller |
NZ535784A (en) | 2002-03-07 | 2006-02-24 | Upfront Chromatography As | A process of isolating lactoferrin |
JP2009513572A (ja) * | 2005-09-28 | 2009-04-02 | ベントリア バイオサイエンス | 腸管障害及び/又は下痢用の経口組成物 |
EP1974735A1 (en) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Reduction of risk of diarrhoea |
IT1392672B1 (it) * | 2009-01-12 | 2012-03-16 | Wyeth Consumer Healthcare S P A | Composizioni comprendenti componenti probiotici e prebiotici e sali minerali, con lactoferrina |
US20120171328A1 (en) | 2011-01-05 | 2012-07-05 | Dattatreya Banavara | Composition comprising heat labile milk proteins and process for preparing same |
US20130095204A1 (en) * | 2011-10-14 | 2013-04-18 | Zeina Jouni | Nutritional phytonutrient compositions |
-
2013
- 2013-03-11 US US13/794,014 patent/US20140255365A1/en not_active Abandoned
-
2014
- 2014-02-11 RU RU2015132613A patent/RU2015132613A/ru unknown
- 2014-02-11 BR BR112015020864A patent/BR112015020864A2/pt not_active IP Right Cessation
- 2014-02-11 WO PCT/US2014/015811 patent/WO2014143471A1/en active Application Filing
- 2014-02-11 PE PE2015001945A patent/PE20151883A1/es not_active Application Discontinuation
- 2014-02-11 AU AU2014228654A patent/AU2014228654B2/en not_active Ceased
- 2014-02-11 SG SG11201505529SA patent/SG11201505529SA/en unknown
- 2014-02-11 CN CN201480013089.3A patent/CN105120888A/zh active Pending
- 2014-02-11 EP EP14708990.8A patent/EP2968305A1/en not_active Withdrawn
- 2014-02-11 CA CA2904221A patent/CA2904221A1/en not_active Abandoned
- 2014-02-11 MX MX2015011540A patent/MX2015011540A/es unknown
- 2014-03-10 AR ARP140100783A patent/AR095082A1/es unknown
-
2015
- 2015-08-17 PH PH12015501803A patent/PH12015501803A1/en unknown
-
2016
- 2016-05-27 HK HK16106044.5A patent/HK1218070A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
HK1218070A1 (zh) | 2017-02-03 |
AU2014228654B2 (en) | 2018-02-15 |
WO2014143471A1 (en) | 2014-09-18 |
CA2904221A1 (en) | 2014-09-18 |
PE20151883A1 (es) | 2016-01-17 |
SG11201505529SA (en) | 2015-08-28 |
AU2014228654A1 (en) | 2015-08-06 |
AR095082A1 (es) | 2015-09-16 |
EP2968305A1 (en) | 2016-01-20 |
BR112015020864A2 (pt) | 2017-07-18 |
US20140255365A1 (en) | 2014-09-11 |
CN105120888A (zh) | 2015-12-02 |
PH12015501803A1 (en) | 2015-11-09 |
RU2015132613A (ru) | 2017-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021003370A (es) | Estado de ayuno como tratamiento dietetico de la diabetes. | |
MX2012011161A (es) | Sistemas, metodos y dispositivos de asistencia cardiaca de combinacion. | |
MX2015006491A (es) | Composiciones bacterianas sinergicas y metodos de produccion y uso de las mismas. | |
MX2015009106A (es) | Composiciones de solución sólida y su uso en el tratamiento del dolor intenso. | |
JO3343B1 (ar) | أحماض 5- أمينوتتراهيدروكوينولين-2- كربوكسيليك جديدة واستخدامها | |
MX2021001169A (es) | Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acético, composiciones, y usos de las mismas. | |
GB201020860D0 (en) | Disulfiram formulation and uses thereof | |
MX365403B (es) | Peptidos y metodos para usarlos. | |
BR112013011259A2 (pt) | condições de tratamento associadas com nível aumentado de eotaxina com 25-hidroxivitamina d3 | |
BR112016023752A2 (pt) | utilização de lactobacillus rhamnosus para promover a recuperação da diversidade da microbiota intestinal após disbiose | |
MX2012007970A (es) | Proceso para la preparacion de una biomasa que comprende plantaricina y usos de la misma en el campo medico. | |
PH12016500025A1 (en) | Methods for promoting neuronal development and/or health | |
PH12015501803A1 (en) | Oral electrolyte solution containing lactoferrin and uses thereof | |
MX2016004328A (es) | Inmunopotenciador. | |
MX351765B (es) | Uso de sales de 3-carboxi-n-etil-n,n-dimetilpropan-1-aminio en el tratamiento de enfermedades cardiovasculares. | |
PH12015500468B1 (en) | Treatment and prevention of acne | |
RU2011122313A (ru) | Способ цитологического исследования базального трахеобронхиального секрета у здоровых лиц при коррекции антиоксидантами воздействия низкой температуры окружающей среды на организм | |
NZ629711A (en) | Anti-inflammatory compositions, methods and uses thereof | |
UA92875U (uk) | Спосіб профілактики серцево-судинних захворювань | |
MX351517B (es) | Solucion de electrolitos baja en calorias. | |
NZ767226A (en) | Egg protein formulations and methods of manufacture thereof | |
TN2013000404A1 (en) | Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease | |
UA104124U (ru) | Способ диагностики воспаления слизистой оболочки толстой кишки при синдроме раздраженного кишечника | |
UA90307U (uk) | Спосіб лікування харчових отруєнь за допомогою яблучного оцту | |
UA103263C2 (ru) | Способ увеличения полового члена и электромеханический экстендер для его реализации |